JeffMichaelMichalskiMDMBA, FACR, FASTRO

Radiation Oncology • Saint Louis, MO

Professor Washington University School of Medicine

Join to view full profile

Dr. Michalski is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Michalski's full profile

Already have an account?

Office
4921 Parkview Pl
Dept Oncology
Saint Louis, MO 63110
Phone+1 314-747-7236

Fax+1 314-362-8099

Summary

Dr. Jeff Michalski is a radiation oncologist in Saint Louis, MO and is affiliated with multiple hospitals in the area, including Barnes-Jewish Hospital, Barnes-Jewish West County Hospital, St. Louis Children's Hospital, Christian Hospital, and Siteman Cancer Center. He received his medical degree from Medical College of Wisconsin and has been in practice 31 years. He also speaks multiple languages, including French. He is experienced in medulloblastoma and prostate cancer.

Education & Training

Washington University/B-JH/SLCH ConsortiumResidency, Radiation Oncology, 1988 - 1991
New York Presbyterian Hospital (Columbia Campus)Internship, Transitional Year, 1986 - 1987
Medical College of WisconsinClass of 1986

Certifications & Licensure

NY State Medical License 1987 - Present
IL State Medical License 1991 - 2026
MO State Medical License 1990 - 2026
UT State Medical License 2020 - 2026
FL State Medical License 2012 - 2020
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2006-2014
America's Top Doctors for Cancer Castle Connolly, 2005-2013
CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012-2013
Top MD Consumers Checkbook
Join now to see all

Clinical Trials

Computer Planned Radiation Therapy Plus Chemotherapy in Treating Patients With Glioblastoma Multiforme Start of enrollment: 1998 Sep 01
Completed
Phase 1, Phase 2
Radiation Therapy in Treating Patients With Stage II Prostate Cancer Start of enrollment: 2002 Mar 01
Completed
Phase 3
Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer Start of enrollment: 2003 Jun 01
Completed
Phase 3
Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma Start of enrollment: 2004 Apr 30
COMPLETED
PHASE3
Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer
ACTIVE_NOT_RECRUITING
PHASE3
Single Photon Emission Computed Tomography (SPECT) Lymph Node Mapping Start of enrollment: 2007 Mar 01
Completed
Not Applicable
Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
ACTIVE_NOT_RECRUITING
PHASE3
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
ACTIVE_NOT_RECRUITING
PHASE3
Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer
ACTIVE_NOT_RECRUITING
PHASE3
Join now to see all

Publications & Presentations

PubMed

Setting the Stage: Feasibility and Baseline Characteristics in the PARTIQoL Trial Comparing Proton Therapy Versus Intensity Modulated Radiation Therapy for Localized P...
Amy J Wisdom, Beow Y Yeap, Jeff M Michalski, Nora K Horick, Anthony L Zietman
International Journal of Radiation Oncology, Biology, Physics. 2025-03-01
The interplay between acute and late toxicity among patients receiving prostate radiotherapy: an individual patient data meta-analysis of six randomised trials.
John Nikitas, Parsa Jamshidian, Alison C Tree, Emma Hall, David Dearnaley
The Lancet. Oncology. 2025-01-30
1 citations
Bladder-Preserving Trimodality Treatment for High-Grade T1 Bladder Cancer: Results From Phase II Protocol NRG Oncology/RTOG 0926.
Douglas M Dahl, Joseph P Rodgers, William U Shipley, M Dror Michaelson, Chin-Lee Wu
Journal of Clinical Oncology. 2024-12-01

Journal Articles

Palliative Radiation Therapy (RT) for Prostate Cancer Patients with Bone Metastases at Diagnosis: A Hospital‐Based Analysis of Patterns of Care, RT Fractionation Schem...
Anthony Apicelli, Jessika Contreras, Michael Roach, Mackenzie Daly, Hiram Gay, Jeff M Michalski, Christopher Abraham, Yuan James Rao, Cancer Medicine
Radiation Therapy as Definitive Local Treatment in Patients with Limited-Stage Small Cell Carcinoma of the Bladder: Does Total Dose Matter?
Soumon Rudra, Jeff Michalski, Jessika Contreras, Hiram Gay, Yuan James Rao, Christopher Abraham, Journal of Pediatric Rehabilitation Medicine
Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer with Adverse Pathological Features
Rahul D. Tendulkar, Kevin L. Stephans, Stanley L. Liauw, Robert B. Den, Shre Agrawal, Mitchel S. Anscher, Jason A. Efstathiou, Thomas M. Pisansky, Jason W. Hearn, Jef ..., JAMA
Intensity Modulated Radiation Therapy and Surgery for Management of Retroperitoneal Sarcomas: A Single-Institution Experience
Todd DeWees, Imran Zoberi, Jeffrey Olsen, Jeff Michalski, William Hawkins, BioMed Central
Join now to see all

Press Mentions

ACR Monitors Hospital and Health Plan Price Transparency DemandsFebruary 28th, 2025
Applied Learning, Empathy in Care Delivery Needed for Health EquityFebruary 10th, 2025
The RBMA Declares That Radiology Is at a CrossroadsFebruary 7th, 2025
Join now to see all

Grant Support

Clinical Trials CoreNational Cancer Institute2010–2011
Advanced Technology QA CenterNational Cancer Institute2009–2011
Core--Clinical Trials FacilityNational Cancer Institute2004–2008

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Other Languages

French